(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KYOWA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KYOWA

ST13

US500000085127602

Class

1, 5

Filing

85127602

Registration

4027937

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

25

Latest update

10/04/2021

Trademark type

Word

Nice classes

1, 5

Filing date

09/11/2010

Registration date

09/20/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/04/2021

Last transaction

10/04/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

Drawing code

4

Owner type

03

Owner location

TOKYO, JP

Examiner

TIERNEY, MARGERY

Law office

M20

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

KYOWA KIRIN CO., LTD.
Kyowa Hakko Kirin Co., Ltd.

Representatives

Kaushal Odedra ODEDRA LAW OFFICE, PLLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Solventsplasticizers; Chemical productsplasticizerssolventsorganic acidsalcoholetheresterketone and aldehyde; Biochemicalsantibodiesmonoclonal antibodiesfragments of such antibodies and derivatives of such antibodies for in vitro scientific or research use; Cells that manufacture antibodyfragment of antibody or derivatives of antibody for scientific laboratory or medical research; Transfected cells that manufactures antibodyfragment of antibody or derivatives of antibody for scientificlaboratory or medical research; Host cells for scientificlaboratory or medical research; Amino acidsciticolineubidecarenoneglutathioneL-Alanyl-L-Glutaminehyaluronic acidsodium hyaluronate. hydroxyprolineacetyl hydroxyproline for use in the manufacture of Pharmaceuticalscosmeticsfood or dietary supplement

Class 5

Vitamins and minerals for use in the manufacture of pharmaceuticals

Publications

History of USPTO decisions and trademark events.

25 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/04/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/04/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/04/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/01/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

05/26/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/20/2020

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/04/2019

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

01/19/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/19/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/19/2018

E815

TEAS SECTION 8 & 15 RECEIVED

12/22/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

09/20/2011

PUBO

PUBLISHED FOR OPPOSITION

07/05/2011

NPUB

NOTICE OF PUBLICATION

06/15/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/02/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/01/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/26/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/26/2011

ALIE

ASSIGNED TO LIE

05/16/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/09/2011

CNRT

NON-FINAL ACTION MAILED

12/20/2010

CNRT

NON-FINAL ACTION WRITTEN

12/20/2010

DOCK

ASSIGNED TO EXAMINER

12/20/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/15/2010

NWAP

NEW APPLICATION ENTERED

09/15/2010

Continuous trademark protection

Get notified about every new filing that threatens KYOWA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.